Gyre Therapeutics (GYRE) Inventory (2022 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Inventory of $11.4 million for Q1 2026, up 44.1% year-over-year from $7.9 million in Q1 2025, and up 11.61% quarter-over-quarter from $10.2 million in Q4 2025.
Gyre Therapeutics (GYRE) Inventory (2022 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Inventory for 5 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 44.1% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 44.1% YoY), while the FY2025 annual figure was $10.2 million, up 60.5% from the prior year.
- Inventory grew to $11.4 million in Q1 2026 per GYRE's latest filing, from $10.2 million in the prior quarter.
- Across five years, Inventory topped out at $11.4 million in Q1 2026 and bottomed at $4.3 million in Q4 2023.
- Historically, Inventory has averaged $7.3 million across 5 years, with a median of $6.4 million in 2024.
- Annual changes were most pronounced in 2023 — Inventory plunged 30.07% — and 2025, when it soared 60.5%.
- Gyre Therapeutics' Inventory stood at $6.1 million in 2022, then sank by 30.07% to $4.3 million in 2023, then jumped by 48.03% to $6.3 million in 2024, then soared by 60.5% to $10.2 million in 2025, then gained by 11.61% to $11.4 million in 2026.
- Business Quant data shows GYRE's Inventory at $11.4 million in Q1 2026, $10.2 million in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | 11.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.43 Mn |
| Mar 31, 2026 | 11.35 Mn |
| Dec 31, 2025 | 10.17 Mn |
| Sep 30, 2025 | 8.85 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 6.34 Mn |
| Sep 30, 2024 | 6.38 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.94 Mn |
| Dec 31, 2023 | 4.28 Mn |
| Dec 31, 2022 | 6.12 Mn |